Abstract:The development of activatable photosensitizers to allow for the reversible control of singlet oxygen (1O2) production for photodynamic therapy (PDT) faces great challenges. Fortunately, the flourishing field of supramolecular biotechnology provides more effective strategies for activatable PDT systems. Here, we developed a new reversible PDT on a switch that controls the 1O2 generation of self-assembled albumin nanotheranostics in vitro and in vivo. A new molecular design principle of aggregation-induced self-quenching photochromism and albumin on-photoswitching was demonstrated using a new asymmetric, synthetic diarylethene moiety DIA. The photosensitizer porphyrin and DIA were incorporated as building blocks in a glutaraldehyde-induced covalent albumin cross-linking nanoplatform, HSA–DIA–porphyrin nanoparticles (NPs). More importantly, the excellent photoswitching property of DIA enables the resultant nanoplatform to act as a facile, switchable strategy for photodynamic-immunotherapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c12851?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c12851</a>.Discussions of materials and methods used, synthetic protocols, synthesis and optimization of HSA–DIA–porphyrin nanoparticles, 1O2 measurement, cell cultures, CLSM evaluation, in vivo PDT treatment and pathology analysis, abscopal effect on 4T1 tumor-bearing mice, and mechanism investigation of the in vivo combined therapy, figures of synthetic pathway, 1H NMR and HRMS spectra, DIA pictures, NanoDIA in different concentrations, absorption spectra, absorption changes, parallel and antiparallel conformations structures, energy-minimized structures, binding modes, free energy of binding, fluorescence spectra, flow cytometric profiles and corresponding quantitative results, cell viability, histological analysis, morbidity-free survival rate, and histograms depicting variations in the routine blood test and kidney functional markers test, table of binding energies (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c12851/suppl_file/ja0c12851_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Bioorthogonal Pretargeting Strategy for Anchoring Activatable Photosensitizers on Plasma Membranes for Effective Photodynamic Therapy

Plasma Membrane Activatable Polymeric Nanotheranostics with Self-Enhanced Light-Triggered Photosensitizer Cellular Influx for Photodynamic Cancer Therapy

Alkyl chain length-regulated in situ intelligent nano-assemblies with AIE-active photosensitizers for photodynamic cancer therapy

Near-infrared photothermal liposomal nanoantagonists for amplified cancer photodynamic therapy

Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer

Activatable Albumin-Photosensitizer Nanoassemblies for Triple-Modal Imaging and Thermal-Modulated Photodynamic Therapy of Cancer.

Acceptor Substitution Engineering of BODIPY-based Organic Photosensitizers with Aggregation-Induced Emission for Organelle Localization and Photodynamic Anticancer Therapy

Activatable Photosensitizer for Smart Photodynamic Therapy Triggered by Reactive Oxygen Species in Tumor Cells

Cascade in Situ Self‐Assembly and Bioorthogonal Reaction Enable the Enrichment of Photosensitizers and Carbonic Anhydrase Inhibitors for Pretargeted Cancer Theranostics

Rationally designed near-infrared AIEgens photosensitizer for cell membrane-targeted photo-driven theranostics

Protein-Activatable Diarylethene Monomer as a Smart Trigger of Noninvasive Control Over Reversible Generation of Singlet Oxygen: A Facile, Switchable, Theranostic Strategy for Photodynamic-Immunotherapy

Synthetic infrared nano-photosensitizers with hierarchical zoom-in target-delivery functionalities for precision photodynamic therapy

Reversible pH-switchable NIR-II nano-photosensitizer for precise imaging and photodynamic therapy of tumors

Molecular Engineering Design of Enhanced Donor-Acceptor Therapeutic Reagent for Efficient Image-Guided Photodynamic Therapy

Tumor-Activated and Metal–Organic Framework Assisted Self-Assembly of Organic Photosensitizers

Bioorthogonal Guided Activation of Cgas‐STING by Aie Photosensitizer Nanoparticles for Targeted Tumor Therapy And Imaging

A Ph-Activatable Nanoparticle for Dual-Stage Precisely Mitochondria-Targeted Photodynamic Anticancer Therapy.

Stable Organic Photosensitizer Nanoparticles with Absorption Peak beyond 800 Nanometers and High Reactive Oxygen Species Yield for Multimodality Phototheranostics

Self-amplified activatable nanophotosensitizers for HIF-1α inhibition-enhanced photodynamic therapy

Hierarchical nano-to-molecular disassembly of boron dipyrromethene nanoparticles for enhanced tumor penetration and activatable photodynamic therapy

Self-assembled nano-photosensitizer for targeted, activatable, and biosafe cancer phototheranostics